What disturbs me is the fact that IMGN finally had a wholly owned approved product and each quarter sales were growing. The confirmational trial had great data, and in fact was approved last week. If they held for 6 more months I think revenue, and therefore price would have been dramatically higher. After four decades in business they could have taken another 6 months or so before going out of it.
News 
Market Data 
Discover 
